Our Bureau, Mumbai Thursday, October 17, 2024, 16:30 Hrs [IST] ...

Annovis Bio gets US FDA clearance to begin pivotal phase 3 studies of buntanetap, paving the way for NDAs filing: Malvern, Pennsylvania Thursday, October 17, 2024, 18:00 Hrs [IST] ...

Immuneering Corporation’s drug candidate IMM-1-104 receives US FDA orphan drug designation for treatment of pancreatic cancer: Cambridge, Massachusetts Thursday, October 17, 202 ...

Our Bureau, Bengaluru Thursday, October 17, 2024, 16:15 Hrs [IST] ...

SkinBB launches Skincare Metaverse, merging AI technology with dermatological expertise for consumer empowerment: Our Bureau, Mumbai Thursday, October 17, 2024, 17:15 Hrs [IST] In ...

Cambridge, Massachusetts Thursday, October 17, 2024, 17:00 Hrs [IST] ...

L V Prasad Eye Institute founder highlights creation of infrastructure for corneal transplants in India: Our Bureau, Bengaluru Thursday, October 17, 2024, 13:30 Hrs [IST] Dr Gulla ...

Merck’s STRIDE-8 phase 3 trial of Capvaxive demonstrates positive immune responses in adults with increased risk for pneumococcal disease: Rahway, New Jersey Thursday, October 1 ...

Monopar expands radiopharma IP portfolio with patent filing on new compounds and linkers: Wilmette, Illinois Thursday, October 17, 2024, 17:30 Hrs [IST] Monopar Therapeutics Inc., ...

Johnson & Johnson announces positive results from phase 2/3 Vibrance-MG study of nipocalimab in adolescents living with generalized myasthenia gravis: Savannah, Georgia Thursday, ...

Gennet Lab and Estonian Embassy inks pact with Sterlite Technologies for healthcare solutions: Our Bureau, Bengaluru Thursday, October 17, 2024, 15:40 Hrs [IST] Gennet Lab, one of ...

City Imaging & Clinical Labs to expand services to 50 hospitals in North India by March 2027: Our Bureau, Bengaluru Thursday, October 17, 2024, 16:50 Hrs [IST] City Imaging & Clin ...